We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORTX
1226
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1K ﹤0.01%
13
ICPT
1227
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
62
PRTK
1228
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
86
SURF
1229
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
77
HARP
1230
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
5
KDNY
1231
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
79
SPPI
1232
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
321
ISEE
1233
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
168
TCRR
1234
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1K ﹤0.01%
63
JNCE
1235
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
75
PRVB
1236
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
106
ATNX
1237
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
9
TCDA
1238
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
110
CLVS
1239
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
166
AKUS
1240
DELISTED
Akouos Inc
AKUS
$1K ﹤0.01%
65
KLDO
1241
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1K ﹤0.01%
68
FLXN
1242
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1K ﹤0.01%
109
KDMN
1243
DELISTED
Kadmon Holdings, Inc.
KDMN
$1K ﹤0.01%
323
BDSI
1244
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1K ﹤0.01%
222
AFYA icon
1245
Afya
AFYA
$1.35B
-2,020
Closed -$51K
AGNG icon
1246
Global X Aging Population ETF
AGNG
$88.9M
-499,650
Closed -$13.9M
APRE icon
1247
Aprea Therapeutics
APRE
$7.69M
$0 ﹤0.01%
2
ASMB icon
1248
Assembly Biosciences
ASMB
$498M
$0 ﹤0.01%
6
AUTL
1249
Autolus Therapeutics
AUTL
$389M
$0 ﹤0.01%
74
BEKE icon
1250
KE Holdings
BEKE
$17.7B
-15,515
Closed -$955K

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.